BioXcel Therapeutics | TalkMarkets

Latest Posts

AI Surge Has Ended: All 7 AI Stock Categories Declined This Week

Article By: Lorimer Wilson

Saturday, April 13, 2024 6:26 PM EDT

From no AI category losses in February, to 3 drops in March - now all 7 fell this week, clearly indicating that that the surge in AI stock prices that began back on October 31st is, indeed, over.

In this article: AIQ, AMD, HON, HPQ, TSM, BIDU, FTNT, ADSK, ANSS, CDNS, MRVL, SHOP, PANW, TEAM, BTAI, DELL, RGTI

Read

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November

Article By: Lorimer Wilson

Wednesday, December 6, 2023 1:53 PM EDT

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

In this article: EXAI, SDGR, ABCL, RLAY, RXRX, BTAI

Read

Dow Up Triple Digits After Bank Stress Test, GDP Revision

Article By: Schaeffers Research

Thursday, June 29, 2023 12:07 PM EDT

The Dow Jones Industrial Average is up 194 points midday, while the S&P 500 Index and Nasdaq Composite move cautiously higher.

In this article: QQQ, SPX, VIX, DJI, BB, BTAI, FREY

Read

Rocket Reversals

Article By: Bespoke Investment Group

Monday, August 10, 2020 11:24 AM EDT

Over the last few days, we’ve been seeing a moderate rotation in the market as red-hot growth stocks sell-off and investors shift into other areas of the market that have been lagging.